Cassava Sciences Inc.

285 articles about Cassava Sciences Inc.

• US FDA Staff Question FDA, King Pharmaceuticals®, Inc. Data

  11/10/2008

• Pain Therapeutics to Present At Two Upcoming Investor Conferences

  11/10/2008

• Pain Therapeutics Announces Third Quarter 2008 Financial Results

  10/29/2008

• Pain Therapeutics to Present At the UBS Warburg Life Sciences Conference

  9/16/2008

• Pain Therapeutics Receives $20,000,000.00 from King Pharmaceuticals®, Inc.

  9/2/2008

• Pain Therapeutics and King Pharmaceuticals®, Inc. Develop a New Abuse-Resistant Prescription Pain Medication

  8/27/2008

• Pain Therapeutics and King Pharmaceuticals®, Inc. Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland

  8/19/2008

• FDA Accepts Pain Therapeutics, King Pharmaceuticals®, Inc. REMOXY New Drug Application and Grants Priority Review

  8/12/2008

• Pain Therapeutics Announces Second Quarter 2008 Financial Results

  7/30/2008

• Pain Therapeutics Encouraged by Results of Melanoma Clinical Study

  6/16/2008

• Pain Therapeutics and King Pharmaceuticals®, Inc. Announce Submission of New Drug Application for Remoxy

  6/10/2008

• Pain Therapeutics to Present At Two Upcoming Investor Conferences

  6/3/2008

• Pain Therapeutics Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell

  5/29/2008

• Pain Therapeutics Announces First Quarter 2008 Financial Results

  5/7/2008

• Pain Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results

  2/7/2008

• Pain Therapeutics Announces New Board Member

  12/11/2007

• Pain Therapeutics Remoxy Meets Primary Endpoint in Pivotal Phase III Study

  12/6/2007

• Pain Therapeutics Announces Third Quarter 2007 Financial Results

  11/1/2007

• Pain Therapeutics Selected for Inclusion in New NASDAQ Index

  9/25/2007

• Pain Therapeutics to Present At Three Upcoming Investor Conferences

  9/12/2007